Smelling Disease: Innovative Diagnostics with eNose

At InterSystems, we partner with healthcare innovators who are changing the future of care around the world. Our customer success program isn’t just about solving complex challenges for healthcare institutions – it’s also about supporting new, innovative startups to scale effectively. 

Partnership, to me, is a crucial commitment at the core of our DNA as a company. I view our customers’ success as our own. The easier it is for a startup to scale access to important data in electronic medical records, for instance, the more successful they can be.  

That’s why I’m excited to share my latest podcast episode exploring how The eNose Company is revolutionizing disease diagnosis through AI-driven breath analysis. By training algorithms to detect biomarkers in exhaled breath, eNose has pioneered an accessible diagnostic tool with far-reaching potential. As you’ll hear from my guests CEO André Elands and Professor Job van der Palen , breath-based screening could expand healthcare access, enable early disease detection, and bridge gaps between health and technology.

We’re proud to support their vision of creating non-invasive, real-time diagnostics that can save lives. Their success is our shared mission. eNose is just one example of many customers who leverage our technology to create exciting new innovations. Stay tuned as I will be highlighting more – and send me a DM if you have a story you think I should share.

To top